SG Americas Securities’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-32,682
Closed -$28K 3936
2020
Q1
$28K Buy
+32,682
New +$46.7K ﹤0.01% 3262
2019
Q4
Sell
-12,697
Closed -$14K 3512
2019
Q3
$14K Sell
12,697
-38,257
-75% -$44.2K ﹤0.01% 2921
2019
Q2
$63K Buy
50,954
+19,889
+64% +$25.3K ﹤0.01% 2882
2019
Q1
$45K Buy
+31,065
New +$46.1K ﹤0.01% 3213
2018
Q3
Sell
-11,353
Closed -$26K 3580
2018
Q2
$26K Buy
+11,353
New +$21.9K ﹤0.01% 3228
2018
Q1
Sell
-101,966
Closed -$78K 3662
2017
Q4
$78K Buy
101,966
+64,701
+174% +$57.8K ﹤0.01% 2909
2017
Q3
$43K Sell
37,265
-38,657
-51% -$48.7K ﹤0.01% 3339
2017
Q2
$132K Buy
+75,922
New +$161K ﹤0.01% 2727
2017
Q1
Sell
-13,361
Closed -$57K 3664
2016
Q4
$57K Buy
+13,361
New +$44K ﹤0.01% 2922
2016
Q2
Sell
-15,691
Closed -$36K 3133
2016
Q1
$36K Sell
15,691
-5,768
-27% -$13K ﹤0.01% 2791
2015
Q4
$74K Buy
+21,459
New +$103K ﹤0.01% 2432
2015
Q2
Sell
-39,098
Closed -$278K 2918
2015
Q1
$278K Buy
+39,098
New +$295K ﹤0.01% 1727

Other funds holding GEN

SG Americas Securities's GEN Position: Q2 2020 in Review

SG Americas Securities sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 32,682 shares — an estimated $28K sold.

SG Americas Securities first reported a position in GEN in Q1 2015 and held it in 12 quarters. The position peaked at $278K in Q1 2015. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

  • SG Americas Securities reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
  • SG Americas Securities sold 32,682 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $28K.
  • SG Americas Securities first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 12 quarters.
  • SG Americas Securities's Genesis Healthcare, Inc. position peaked at $278K in Q1 2015.
  • 58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on SG Americas Securities's 13F filing for Q2 2020, filed 20 Jul 2020.